Leiter, L. A., Müller‐Wieland, D., Baccara‐Dinet, M. T., Letierce, A., Samuel, R., & Cariou, B. (2017). Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: A pooled analysis of 10 phase III ODYSSEY clinical trials. Diabet Med.

Leiter, L. A., D. Müller‐Wieland, M. T. Baccara‐Dinet, A. Letierce, R. Samuel, e B. Cariou. "Efficacy and Safety of Alirocumab in People With Prediabetes Vs Those With Normoglycaemia At Baseline: A Pooled Analysis of 10 Phase III ODYSSEY Clinical Trials." Diabet Med 2017.

Leiter, L. A., et al. "Efficacy and Safety of Alirocumab in People With Prediabetes Vs Those With Normoglycaemia At Baseline: A Pooled Analysis of 10 Phase III ODYSSEY Clinical Trials." Diabet Med 2017.